Company intelligence / Profile preview
Centaur Pharmaceuticals
Mumbai, Maharashtra, Indiacentaurpharma.com ↗
- Ownership
- Private
- Employees
- ~3786
- Development stage
- Phase 2
01
Overview
Centaur Pharmaceuticals is a fully integrated pharmaceutical company with products across multiple therapeutic areas. Recently launched generic ivabradine hydrochloride tablets in the US with 180-day exclusivity. Also developed WOXheal, a novel topical solution for diabetic foot ulcers.
- Therapeutic areas
- PulmonologyCardiovascularNephrologyEndocrinologyImmunologyNeurology
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Strategic alliance with American Biotech company for RenadylGerman collaboration for WOXhealIngenus Pharmaceuticals for US marketing
Beyond the preview
Go deeper on Centaur Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Centaur Pharmaceuticals.